Showing results (441-450 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|November 15, 2021
Predictors of Population Awareness of Cancer Genetic Tests: Implications for Enhancing Equity in Engaging in Cancer Prevention and Precision MedicineVeda N Giri, Ayako Shimada, Amy E Leader
JCO Precision Oncology|November 25, 2021
KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver MetastasesIris van 't Erve, Nina J Wesdorp, Jamie E Medina, et al.
JCO Precision Oncology|January 7, 2022
Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs)Kimberly Perez, Matthew H Kulke, Anu Chittenden, et al.
JCO Precision Oncology|January 7, 2022
ctDNA Predicts Overall Survival in Patients With NSCLC Treated With PD-L1 Blockade or With ChemotherapyWei Zou, Stephanie J Yaung, Frederike Fuhlbrück, et al.
JCO Precision Oncology|January 7, 2022
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP)Andrés F Cardona, Camila Ordóñez-Reyes, Alejandro Ruiz-Patiño, et al.
JCO Precision Oncology|January 7, 2022
Phase II Single-Arm Study to Assess Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2-Negative Tumors and HER2-Positive Circulating Tumor CellsHeather A Parsons, Erin R Macrae, Hao Guo, et al.
JCO Precision Oncology|January 7, 2022
Next-Generation Sequencing of Patients With Breast Cancer in Community Oncology ClinicsEmma G Sturgill, Amanda Misch, Rebecca Lachs, et al.
JCO Precision Oncology|January 7, 2022
Tumor-Specific and Tumor-Agnostic Molecular Signatures Associated With Response to Immune Checkpoint InhibitorsDaniel Schlauch, Xiaotong Fu, Suzanne F Jones, et al.
JCO Precision Oncology|January 10, 2022
Isocitrate Dehydrogenase-Mutated Cholangiocarcinoma: Natural History and Clinical OutcomesGrant Wintheiser, Tyler Zemla, Qian Shi, et al.
JCO Precision Oncology|January 20, 2022
No Evidence of Increased Risk of Breast Cancer in Women With Lynch Syndrome Identified by Multigene Panel TestingJessica Stoll, Eric Rosenthal, Shelly Cummings, et al.
Pageof 140